MIR22HG is demonstrated as a tumor suppressor through TGF-β/SMAD signaling in colorectal cancer, whose depletion can promote EMT process and tumor metastasis (Xu et al., 2020). The gene discussed is MIR22HG; the disease is neoplasm.